Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medipal HoldingsMAHLY 74 Buyback Yield % is 1.50 as of Jul. 17, 2026, which is 26% above its 10-year median of 1.19. GuruFocus rates MAHLY with a GF Score™ of 74/100 and a GF Value™ of $16.38 (Fairly Valued). The stock has 1 warning sign investors should review. Among 39 Medical Distribution companies, Medipal Holdings ranks better than 61.54% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Medipal Holdings's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MAHLY vs MCK, CAH, COR: Buyback Yield % Comparison
For the Medical Distribution subindustry, Medipal Holdings's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medipal Holdings Buyback Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Medipal Holdings's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Medipal Holdings's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medipal Holdings (MAHLY) has a Buyback Yield % of 1.50 as of Jul. 17, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Medipal Holdings and its competitors. This is 26% above median its historical median of 1.19. According to the industry distribution chart, Medipal Holdings ranks #15 out of 39 companies in the Medical Distribution industry, placing it in the top 38.5%.
Is Medipal Holdings' Buyback Yield % too high?
Medipal Holdings' current Buyback Yield % of 1.50 is 26% above median its 10-year median of 1.19. The Medical Distribution industry median Buyback Yield % is 0.05. Medipal Holdings' value of 1.50 is 2900% above this industry median. Based on the distribution chart, Medipal Holdings ranks #15 out of 39 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Medipal Holdings has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medipal Holdings' Buyback Yield % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Medipal Holdings ranks #15 out of 39 companies for Buyback Yield %. This puts Medipal Holdings in the upper half of its industry. The industry median Buyback Yield % is 0.05. Medipal Holdings' value of 1.50 is 2900% above this benchmark. While the company's 10-year median is 1.19 vs. the industry median of 0.05, Medipal Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Distribution company?
The median Buyback Yield % among Medical Distribution companies is 0.05, based on 39 companies in the industry. Companies in the top quartile (top 25%) have a Buyback Yield % significantly above this median, while those in the bottom quartile fall well below. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medipal Holdings's current Buyback Yield % of 1.50 is 2900% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Medipal Holdings and its competitors. For the Medical Distribution industry, the median Buyback Yield % is 0.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medipal Holdings's current Buyback Yield % is 1.50, which is 26% above median its own 10-year median of 1.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medipal Holdings stock overvalued right now?
Based on GuruFocus' analysis, Medipal Holdings (MAHLY) is currently considered Fairly Valued. The stock's GF Value™ is $16.38, compared to a current price of $17.99 — trading 9.8% above its estimated fair value. The current Buyback Yield % is 1.50, which is 26% above median its 10-year median of 1.19 and 2900% above the Medical Distribution industry median of 0.05. Medipal Holdings' overall GF Score™ is 74/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Medipal Holdings (MAHLY), the current Buyback Yield % is 1.50 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medipal Holdings (MAHLY) Overvalued in 2026?
Based on GuruFocus' analysis, Medipal Holdings stock appears to be overvalued.
The current stock price of $17.99 is trading 9.8% above its estimated GF Value™ of $16.38.
GuruFocus considers Medipal Holdings to be Fairly Valued.
Key valuation signals for MAHLY:
Buyback Yield %: 1.50 (26% above median its 10-year median of 1.19)
GF Value™: $16.38 vs. price of $17.99 (9.8% above fair value)
Industry Position: 2900% above the Medical Distribution median (#15 of 39)
No single metric tells the full story. See the MAHLY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medipal Holdings Corp is engaged in the wholesale distribution of pharmaceuticals, cosmetics, daily necessities, and related products. The company operates through three reportable segments: Wholesale business of medical drugs; Cosmetics, Daily Necessities and OTC Pharmaceuticals Wholesale Business; and Wholesale of animal medicines and food processing ingredients. The Wholesale business of medical drugs segment targets hospitals, clinics, and dispensing pharmacies; the Cosmetics and OTC segment serves drug stores, home centers, convenience stores, and supermarkets; while the Wholesale of animal medicines and food processing ingredients segment supplies veterinary clinics, livestock and fisheries businesses, and food manufacturers.
74GF Score
Get the complete analysis for MAHLY
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MAHLY has been successfully added to your 
